InvestorsHub Logo

Big Poppa Pump

08/15/17 3:11 PM

#519 RE: jackwelsch2016 #517

ENUM selling off there "intellectual property isn't anything new here.

Pieris Pharmaceutical(PIRS) on the NYSE which is trading around 4.72, has had an agreement with Enumeral to buy their PD-1 antibody. They couldn't get anything done by May 31 so the deal was terminated.

http://www.businesswire.com/news/home/20160418005451/en/Enumeral-Pieris-Pharmaceuticals-Enter-License-Transfer-Agreement

Pieris just had a CC last week.
https://seekingalpha.com/article/4097674-pieris-pharmaceuticals-pirs-ceo-stephen-yoder-q2-2017-results-earnings-call-transcript?part=single

Take a look at the call, they're still interested in the PD-1 Antibody. This isn't over yet!



Another thing that sticks out, 180 Degree Capital Corp just funded Enumeral earlier this month, to get 8M in shares. Something is going on here.

The person who got that 2.8M today is willing to take the risk here.